Web28 feb. 2015 · HUTCHMED currently retains all rights to HMPL-653 worldwide. HMPL-A83 HMPL-A83 is an investigational novel IgG4-type humanized anti-CD47 monoclonal … WebYing Du. Ying Du is an entrepreneur who founded Zai Lab Ltd., Hutchison MediPharma Ltd. and Zai Venture Partners. Presently, she is Chairman & Chief Executive Officer of …
03/04/2024 Journal - Intellectual Property Office
Web和黄医药是一家处于商业化阶段的创新型生物医药公司,旨在成为发现、 开发及商业化治疗癌症及免疫性疾病靶向治疗及免疫疗法的全球领导者。 了解更多,请访问我们的 全球官 … Web4 mrt. 2024 · Date Published Date of Application in Bailiwick Patent Title Field of Invention Registered Proprietor Overseas Registration, Jurisdiction, Number & Link to Web subtitles house of the dragon
ESMO Congress OncologyPRO
WebResearch Interest. Dr. Sai earned his B.S. in pharmacy from the 2nd Military Medical University, his M.S. in pharmacology and toxicology from the Beijing Institute of … WebHutchison MediPharma Limited (the “Company” or “Party A”) Legal Address : Building 4, 720 Cailun Road, Zhangjiang Hi-Tech Park Pudong, Shanghai, China Web4 Apr 2024 HUTCHMED Initiates Registration Phase Enrollments of HMPL-453 for IHCC and Savolitinib for Gastric Cancer following NMPA Consultations 31 Mar 2024 … HUTCHMED is an innovative, commercial-stage biopharmaceutical company … Commercialization Over the past two decades, we have operated in China’s … We further plan to enrich our global pipeline of self-discovered drug candidates by … News & Press Releases 12 Apr 2024 HUTCHMED Highlights Presentations at … Disclosure reference pursuant to Rule 26 'Company Information' of the AIM Rules … Job Title: (Senior) QA Supervisor, Release Location: Shanghai Responsibilities … Our comprehensive drug discovery and development operation covers … Our prescription drugs business, conducted through our joint ventures (Shanghai … subtitles house of wax